Harbin Pharmaceutical Group

Last updated
  1. "HPGC 2022 Semi-Annual Report". Shanghai Stock Exchange. Retrieved November 12, 2022.
  2. "Harbin Pharmaceutical to issue RMB 800 mln short-term bonds". news.alibaba.com. 10 November 2008. Retrieved 2020-09-13.
  3. Ferek, Katy Stech (2020-09-10). "Rubio Seeks Security Review of Chinese Bid for GNC". Wall Street Journal. ISSN   0099-9660 . Retrieved 2020-09-13.
  4. Stevenson, Alexandra; Kulish, Nicholas; Gelles, David (2020-04-24). "Frantic for Coronavirus Gear, Americans in Need Turn to China's Elite". The New York Times. ISSN   0362-4331 . Retrieved 2020-09-13.
  5. "Harbin Pharmaceutical Group Co Ltd - Company Profile and News". Bloomberg.com. Retrieved 2021-03-26.
  6. "GNC Taps 5WPR For Consumer Business". www.provokemedia.com. Retrieved 2021-04-08.
  7. "GNC, China's Harbin Pharmaceutical agree on sale price before auction". New Hope Network. 2020-08-10. Retrieved 2021-04-08.
  8. Yukun, Liu; Hu, Yuanyuan (2018-02-26). "Hayao picks 40% stake in GNC, to also form new JV". China Daily. Retrieved 2022-11-12.
  9. Wang, Qiwen (2022-03-11). "不止茅台,东阿阿胶、哈药等「国家企业技术中心」资格也被撤". The Paper (in Chinese). Archived from the original on 2022-11-12. Retrieved 2022-11-12.
Harbin Pharmaceutical Group Co., Ltd.
Type Public
SSE: 600664
IndustryPharmaceuticals
PredecessorHarbin Pharmaceutical Administration
Founded1988;35 years ago (1988)
Headquarters,
China
Area served
Worldwide
Owner
Number of employees
20,100 (2014)
Subsidiaries
Chinese name
Simplified Chinese 哈药集团有限公司
Traditional Chinese 哈藥集團有限公司